SOCS4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.82209827623592E-11 |
Normal-vs-Stage2 |
5.10789999963457E-07 |
Normal-vs-Stage3 |
4.32986979603811E-15 |
Normal-vs-Stage4 |
1.89415150231298E-12 |
Stage1-vs-Stage2 |
4.023600E-01 |
Stage1-vs-Stage3 |
1.635660E-03 |
Stage1-vs-Stage4 |
1.861710E-03 |
Stage2-vs-Stage3 |
3.068400E-01 |
Stage2-vs-Stage4 |
2.226400E-01 |
Stage3-vs-Stage4 |
7.125200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6295853555448E-12 |
Normal-vs-AfricanAmerican |
2.3374000512888E-09 |
Normal-vs-Asian |
2.983900E-02 |
Caucasian-vs-AfricanAmerican |
6.349800E-01 |
Caucasian-vs-Asian |
6.021200E-01 |
AfricanAmerican-vs-Asian |
4.405000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
3.58959972857065E-10 |
Male-vs-Female |
3.156400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.07520004011263E-09 |
Normal-vs-Age(41-60Yrs) |
1.08379971663908E-10 |
Normal-vs-Age(61-80Yrs) |
1.62558855265615E-12 |
Normal-vs-Age(81-100Yrs) |
2.43860000004315E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.713630E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.532000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.849000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.283400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.274600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.101800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.867600E-02 |
Normal-vs-Grade 2 |
1.39629999784674E-08 |
Normal-vs-Grade 3 |
1.00808250635964E-13 |
Normal-vs-Grade 4 |
1.63302704692114E-12 |
Grade 1-vs-Grade 2 |
4.366400E-01 |
Grade 1-vs-Grade 3 |
2.094300E-02 |
Grade 1-vs-Grade 4 |
5.822700E-03 |
Grade 2-vs-Grade 3 |
1.015690E-03 |
Grade 2-vs-Grade 4 |
6.42189999999765E-05 |
Grade 3-vs-Grade 4 |
7.720400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.21239999945666E-08 |
Normal-vs-ccB subtype |
1.63358215843346E-12 |
ccA subtype-vs-ccB subtype |
2.235300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.60800278542683E-12 |
Normal-vs-N1 |
4.08739999957497E-07 |
N0-vs-N1 |
9.997500E-02 |
|
|